HAIXI PHARM INT HLDG LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - AUD | -.--% |
|
-.--% | -.--% |
| Managers | Title | Age | Since |
|---|---|---|---|
Jack Wang
CHM | Chairman | - | - |
Da Peng
DFI | Director of Finance/CFO | - | - |
Chen Chik Ong
BRD | Director/Board Member | 45 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chen Chik Ong
BRD | Director/Board Member | 45 | - |
Fook Weng Au
BRD | Director/Board Member | - | - |
Jack Wang
CHM | Chairman | - | - |
Haixi Pharmaceutical International Holdings Limited is an Australia-based holding company. The Company is engaged in the manufacturing, sales, and research and development of pharmaceutical medicinal products. The Company provides over the counter ointment and medicinal creams to treat pain, swelling and itching. The Company's products include Viaminate and Vitamin E Cream, Compound Camphor Cream, Terbinafine Hydrochloride Cream, Aciclovir Cream, Bifonazole Cream, Ketoconazole Cream and Benzoyl Peroxide Gel. Fujian Yong'an Pharmaceutical Co., Ltd. is subsidiary of the Company.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 0 | |
| +33.25% | 704B | |
| +28.59% | 577B | |
| -3.55% | 348B | |
| +18.16% | 327B | |
| +4.36% | 288B | |
| +14.81% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -3.69% | 147B |
- Stock Market
- Equities
- HXP Stock
